Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1987 Sep;50(9):1234–1235. doi: 10.1136/jnnp.50.9.1234

Movement disorder associated with abnormal copper metabolism and decreased blood antioxidants.

H S Pall, A C Williams, D R Blake, P Winyard, S Chirico, S Brailsford
PMCID: PMC1032364  PMID: 3668575

Full text

PDF
1234

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbeau A. Etiology of Parkinson's disease: A research strategy. Can J Neurol Sci. 1984 Feb;11(1):24–28. doi: 10.1017/s0317167100045273. [DOI] [PubMed] [Google Scholar]
  2. Crowley C., Gillham B., Thorn M. B. A direct enzymic method for the determination of reduced glutathione in blood and other tissues. Biochem Med. 1975 Jul;13(3):287–292. doi: 10.1016/0006-2944(75)90087-3. [DOI] [PubMed] [Google Scholar]
  3. Dormandy T. L. Free-radical oxidation and antioxidants. Lancet. 1978 Mar 25;1(8065):647–650. doi: 10.1016/s0140-6736(78)91148-0. [DOI] [PubMed] [Google Scholar]
  4. Gutteridge J. M. Copper-phenanthroline-induced site-specific oxygen-radical damage to DNA. Detection of loosely bound trace copper in biological fluids. Biochem J. 1984 Mar 15;218(3):983–985. doi: 10.1042/bj2180983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Malhotra K. M., Murthy R. C., Srivastava R. S., Chandra S. V. Concurrent exposure of lead and manganese to iron-deficient rats: effect on lipid peroxidation and contents of some metals in the brain. J Appl Toxicol. 1984 Feb;4(1):22–25. doi: 10.1002/jat.2550040105. [DOI] [PubMed] [Google Scholar]
  6. Que B. G., Downey K. M., So A. G. Degradation of deoxyribonucleic acid by a 1,10-phenanthroline-copper complex: the role of hydroxyl radicals. Biochemistry. 1980 Dec 23;19(26):5987–5991. doi: 10.1021/bi00567a007. [DOI] [PubMed] [Google Scholar]
  7. Quinn N. P., Marsden C. D. Coincidence of Wilson's disease with other movement disorders in the same family. J Neurol Neurosurg Psychiatry. 1986 Feb;49(2):221–222. doi: 10.1136/jnnp.49.2.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ross M. E., Jacobson I. M., Dienstag J. L., Martin J. B. Late-onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings. Ann Neurol. 1985 Apr;17(4):411–413. doi: 10.1002/ana.410170421. [DOI] [PubMed] [Google Scholar]
  9. Willvonseder R., Goldstein N. P., McCall J. T., Yoss R. E., Tauxe W. N. A hereditary disorder with dementia, spastic dysarthria, vertical eye movement paresis, gait disturbance, splenomegaly, and abnormal copper metabolism. Neurology. 1973 Oct;23(10):1039–1049. doi: 10.1212/wnl.23.10.1039. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES